Tele-Collaborative Outreach to Rural Patients With Chronic Pain
CORPs
3 other identifiers
interventional
608
1 country
4
Brief Summary
This is a randomized controlled trial comparing the effectiveness of a remotely delivered collaborative care intervention for chronic pain versus a minimally enhanced control group. The specific aims of the study are: (1) compare the effectiveness of tele-collaborative pain care vs. minimally enhanced usual care to improve pain interference over 12 months of follow-up, and (2) oversample women and rural veterans of minoritized race/ethnicity to test heterogeneity of treatment effects across birth sex and race/ethnicity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 chronic-pain
Started Jul 2024
Longer than P75 for phase_3 chronic-pain
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 13, 2023
CompletedFirst Posted
Study publicly available on registry
October 19, 2023
CompletedStudy Start
First participant enrolled
July 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
July 20, 2025
June 1, 2025
2.8 years
October 13, 2023
July 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Interference - Brief Pain Inventory (BPI)
Pain Interference subscale from the Brief Pain Inventory. Scores are reported on a range of 0 - 10, with higher scores indicating more impairment due to pain.
Baseline, 3-, 6-, 9-, and 12 Months
Secondary Outcomes (8)
Pain Intensity - Brief Pain Inventory (BPI)
Baseline, 3-, 6-, 9-, and 12 Months
Physical Functioning - PROMIS Physical Functioning Scale
Baseline, 3-, 6-, 9-, and 12 Months
Quality of Life - Veterans RAND-12 (VR-12)
Baseline, 3-, 6-, 9-, and 12 Months
Depressive Symptoms - Patient Health Questionnaire-9 (PHQ-9)
Baseline, 3-, 6-, 9-, and 12 Months
Anxiety Symptoms - Generalized Anxiety Disorder-7 (GAD-7)
Baseline, 3-, 6-, 9-, and 12 Months
- +3 more secondary outcomes
Study Arms (2)
CORPs Intervention
ACTIVE COMPARATORThe CORPs Intervention is a nurse-led intervention. A) An intake assessment with a Nurse Care Manager at the start of the study by phone or video to discuss the patient's pain experience, care options, and goals. Resources are provided and focus on non-medication options at the VA, and as appropriate, in the community. B) 5 Check-in phone/video appointments with a Nurse Care Manager, scheduled to take place near 2-, 4-, 8-, 12-, and 16-weeks. These visits will provide further assistance with goal planning and care coordination for pain management. C) Optional 6-week virtual group education class covering topics like complementary and integrative approaches to pain, sleep and pain, and the neurobiology of pain. D) Patients in this arm can contact their nurse with questions for the full 12 months of participation.
Minimally Enhanced Usual Care (MEUC)
PLACEBO COMPARATORThe minimally enhanced usual care arm is a one-time education session. A) One-time education session with a Nurse Care Manager by phone/video to review pain resources. These resources focus on non-medication options at the VA, and as appropriate, in the community.
Interventions
Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference. After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months. A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.
Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference. After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months. A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.
Eligibility Criteria
You may qualify if:
- U.S. Veteran
- Rural Residence based on Rural Urban Commuting Area codes
- High Impact Chronic pain, determined through a phone screening
- Access to landline or cell phone
- English Speaking
You may not qualify if:
- Cognitive impairment that would impact participation in the study
- Plans to move in the next 3 months
- Surgery in the past 3 months
- In long-term inpatient or hospice care
- Terminal illness (defined as life expectancy of less than 12 months)
- Active participation in another pain intervention study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oregon Health and Science Universitylead
- National Center for Complementary and Integrative Health (NCCIH)collaborator
- Portland VA Medical Centercollaborator
- Minneapolis Veterans Affairs Medical Centercollaborator
- North Texas Veterans Healthcare Systemcollaborator
- VA Tennessee Valley Health Care Systemcollaborator
Study Sites (4)
VA Minneapolis Health Care System
Minneapolis, Minnesota, 55417, United States
VA Portland Health Care System
Portland, Oregon, 97239, United States
VA Tennessee Valley Health Care System
Nashville, Tennessee, 37212, United States
VA North Texas Health Care System
Dallas, Texas, 75216, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Travis Lovejoy, PhD, MPH
Oregon Health & Science University, VA Portland Health Care System
- PRINCIPAL INVESTIGATOR
Benjamin Morasco, PhD
Oregon Health & Science University, VA Portland Health Care System
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 13, 2023
First Posted
October 19, 2023
Study Start
July 11, 2024
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
July 20, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share